[go: up one dir, main page]

AU2002226075A1 - Cadherin peptides for drug delivery and inhibition of tumor metastasis/invasion - Google Patents

Cadherin peptides for drug delivery and inhibition of tumor metastasis/invasion

Info

Publication number
AU2002226075A1
AU2002226075A1 AU2002226075A AU2607502A AU2002226075A1 AU 2002226075 A1 AU2002226075 A1 AU 2002226075A1 AU 2002226075 A AU2002226075 A AU 2002226075A AU 2607502 A AU2607502 A AU 2607502A AU 2002226075 A1 AU2002226075 A1 AU 2002226075A1
Authority
AU
Australia
Prior art keywords
invasion
inhibition
drug delivery
tumor metastasis
cadherin peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002226075A
Inventor
Seetharama D.S. Jois
Irwan Makagiansar
Teruna J Siahaan
Ernawati Sinaga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kansas
Original Assignee
University of Kansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Kansas filed Critical University of Kansas
Publication of AU2002226075A1 publication Critical patent/AU2002226075A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002226075A 2000-10-23 2001-10-23 Cadherin peptides for drug delivery and inhibition of tumor metastasis/invasion Abandoned AU2002226075A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69453800A 2000-10-23 2000-10-23
US09/694,538 2000-10-23
PCT/US2001/047753 WO2002034880A2 (en) 2000-10-23 2001-10-23 Cadherin peptides for drug delivery and inhibition of tumor metastasis/invasion

Publications (1)

Publication Number Publication Date
AU2002226075A1 true AU2002226075A1 (en) 2002-05-06

Family

ID=24789242

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002226075A Abandoned AU2002226075A1 (en) 2000-10-23 2001-10-23 Cadherin peptides for drug delivery and inhibition of tumor metastasis/invasion

Country Status (2)

Country Link
AU (1) AU2002226075A1 (en)
WO (1) WO2002034880A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050266554A1 (en) 2004-04-27 2005-12-01 D Amour Kevin A PDX1 expressing endoderm
WO2005063971A2 (en) 2003-12-23 2005-07-14 Cythera, Inc Definitive endoderm
US7985585B2 (en) 2004-07-09 2011-07-26 Viacyte, Inc. Preprimitive streak and mesendoderm cells
US7625753B2 (en) 2003-12-23 2009-12-01 Cythera, Inc. Expansion of definitive endoderm cells
US8586357B2 (en) 2003-12-23 2013-11-19 Viacyte, Inc. Markers of definitive endoderm
US8647873B2 (en) 2004-04-27 2014-02-11 Viacyte, Inc. PDX1 expressing endoderm
WO2006020919A2 (en) 2004-08-13 2006-02-23 University Of Georgia Research Foundation, Inc. Compositions and methods for self-renewal and differentiation in human embryonic stem cells
DK1957636T3 (en) 2005-10-27 2018-10-01 Viacyte Inc PDX1-EXPRESSING DORSAL AND VENTRAL FORTARM ENDODERM
GB0602063D0 (en) 2006-02-02 2006-03-15 Univ Manchester Cell Culture
US11254916B2 (en) 2006-03-02 2022-02-22 Viacyte, Inc. Methods of making and using PDX1-positive pancreatic endoderm cells
DK2650360T3 (en) 2006-03-02 2019-10-07 Viacyte Inc Endocrine precursor cells, pancreatic hormone-expressing cells, and methods of preparation
US7695965B2 (en) 2006-03-02 2010-04-13 Cythera, Inc. Methods of producing pancreatic hormones
US7695963B2 (en) * 2007-09-24 2010-04-13 Cythera, Inc. Methods for increasing definitive endoderm production
WO2009055937A1 (en) * 2007-11-01 2009-05-07 The Royal Institution For The Advancement Of Learning/Mcgill University Altered n-cadherin processing in tumor cells by furln and proproteln convertase 5a (pc5a)
ES2667493T3 (en) 2008-11-14 2018-05-11 Viacyte, Inc. Encapsulation of pancreatic cells derived from pluripotent human stem cells
MX357167B (en) * 2010-10-27 2018-06-28 Univ New York State Res Found Compositions targeting the soluble extracellular domain of e-cadherin and related methods for cancer therapy.
US20130058947A1 (en) * 2011-09-02 2013-03-07 Stem Centrx, Inc Novel Modulators and Methods of Use
US9534058B2 (en) 2012-02-08 2017-01-03 Abbvie Stemcentrx Llc Anti-CD324 monoclonal antibodies and uses thereof
US11591564B2 (en) 2016-12-16 2023-02-28 University of Pittsburgh—of the Commonwealth System of Higher Education Peptide conjugated hydrogel substrate for the maintenance and expansion of human pluripotent stem cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0856655A (en) * 1994-08-16 1996-03-05 Frontier:Kk Cell lethal agent and cell death inhibitor
JP2001500475A (en) * 1996-07-12 2001-01-16 マクギル ユニバーシティ Compounds and methods for modulating cell adhesion
US6169071B1 (en) * 1996-07-12 2001-01-02 Mcgill University Compounds and methods for modulating cell adhesion
US5985608A (en) * 1997-10-31 1999-11-16 University Of Massachusetts Actin-binding polypeptides and nucleic acids encoding the same
US6248864B1 (en) * 1997-12-31 2001-06-19 Adherex Technologies, Inc. Compounds and methods and modulating tissue permeability

Also Published As

Publication number Publication date
WO2002034880A2 (en) 2002-05-02
WO2002034880A3 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
AU2002226075A1 (en) Cadherin peptides for drug delivery and inhibition of tumor metastasis/invasion
AU6168699A (en) Non-compliant system for delivery of implant material
HUP0105077A3 (en) Serine protease inhibitors and pharmaceutical compositions containing them
AU2002322719A1 (en) Delivery of therapeutic capable agents
AU3869400A (en) Human cancer associated gene sequences and polypeptides
AU2002338806A1 (en) Pharmaceutical combinations of pde-v inhibitors and other agents
AU2002367104A1 (en) Transcription regulatory gene and peptide
AU2003222067A1 (en) System for delivery of therapeutic substances
IL152593A0 (en) Liposome drug delivery
IL139308A0 (en) Peptides from amyloid precursor protein which inhibit tumor growth and metastasis
AU2002361098A1 (en) Pyroglutamyl peptidase and its gene
AU6887401A (en) Delivery of remotely-ordered products
AU2001238346A1 (en) Modification of biopolymers for improved drug delivery
AU2001268467A1 (en) Identification of genes and compounds for treatment of cancer
GB0119012D0 (en) Transdermal delivery of drugs
AU2003301444A1 (en) System for delivery of active substances
AU4711000A (en) Vector-mediated delivery of integrating transposon sequences
AU2001297611A1 (en) Pharmaceutical uses and synthesis of diketopiperazines
AU2001238485A1 (en) Methods and compositions for gene delivery
AU1280701A (en) Iontophoretic transdermal delivery of peptides
AU2002223313A1 (en) Protease inhibitors and their pharmaceutical uses
AU4369800A (en) Treatment of metastatic cancer through mts-1 gene
GB2351494B (en) Interactions of Ku peptides and applications thereof
AU2002223545A1 (en) Delivery of location-specific information
AU4053700A (en) Enhanced tissue and subcellular delivery of vitamin e compounds